Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Wall Street’s Favorite Renewable Energy Stocks? 3 Names That Could Make You Filthy Rich

Even with oil above $80 a barrel, there's still time to consider some of Wall Street’s favorite renewable energy stocks

Affordable Stocks on the Horizon? 3 Companies to Watch for Stock Splits

The potential to attract investors with a lower price puts these companies on a list of stocks to watch for stock splits in 2024.

Wall Street Favorites: 7 Under-$20 Stocks With Strong Buy Ratings for March 2024 

Finding strong buy stocks under-$20 takes a little effort, but as these stocks show they can be profitable additions to your portfolio.

The 3 Most Undervalued Value Stocks to Buy in March 2024 

These undervalued value stocks have solid fundamentals that present an attractive risk-reward ratio for patient investors.

3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold

If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.